Quantum Genomics Société Anonyme (QNNTF)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -1.41 Million EUR | 94.58% |
| 2022 | -28.89 Million EUR | -47.76% |
| 2021 | -19.55 Million USD | -7.24% |
| 2020 | -18.23 Million USD | -1159.2% |
| 2019 | 1.72 Million USD | 8019.87% |
| 2018 | -21.74 Thousand USD | 30.01% |
| 2017 | -31.06 Thousand USD | 99.24% |
| 2016 | -4.08 Million USD | -33.22% |
| 2015 | -3.06 Million USD | 5.65% |
| 2014 | -3.25 Million USD | -27.81% |
| 2013 | -2.54 Million USD | -32.78% |
| 2012 | -1.91 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | - USD | 0.0% |
| 2023 FY | -3.32 Million USD | 88.48% |
| 2023 Q3 | -285.29 Thousand USD | 86.49% |
| 2023 Q4 | -297.92 Thousand USD | -4.43% |
| 2023 Q2 | -2.11 Million USD | -342.8% |
| 2023 Q1 | -477.04 Thousand USD | 95.27% |
| 2022 FY | -28.89 Million EUR | -47.76% |
| 2022 Q4 | -10.09 Million USD | -9.27% |
| 2022 Q3 | -9.23 Million USD | 17.74% |
| 2022 Q2 | -11.22 Million USD | 0.0% |
| 2021 Q2 | -11.21 Million USD | 0.0% |
| 2021 FY | -19.55 Million USD | -7.24% |
| 2020 FY | -18.23 Million USD | -1159.2% |
| 2019 Q4 | -5753.93 USD | 0.0% |
| 2019 FY | 1.72 Million USD | 8019.87% |
| 2019 Q2 | -7856.58 USD | 0.0% |
| 2018 Q4 | -8974.87 USD | 0.0% |
| 2018 FY | -21.74 Thousand USD | 30.01% |
| 2018 Q2 | -13.03 Thousand USD | 0.0% |
| 2017 Q4 | -14.09 Thousand USD | 0.0% |
| 2017 FY | -31.06 Thousand USD | 99.24% |
| 2017 Q2 | -16.11 Thousand USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | -4.08 Million USD | -33.22% |
| 2015 FY | -3.06 Million USD | 5.65% |
| 2014 FY | -3.25 Million USD | -27.81% |
| 2013 FY | -2.54 Million USD | -32.78% |
| 2012 FY | -1.91 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 109.463% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 45853.997% |
| SQZ Biotechnologies Company | 9.79 Million USD | 114.491% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 112.124% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 101.192% |
| Mesoblast Limited | -35.16 Million USD | 95.964% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | -4056.044% |
| Genus plc | 178.7 Million USD | 100.794% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 446.029% |
| Marizyme, Inc. | 457.7 Thousand USD | 410.09% |
| ContraFect Corporation | -154 Thousand USD | -821.616% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | -12802.627% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | -2738.578% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 1948.971% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 2259.337% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | -266.267% |
| MultiCell Technologies, Inc. | 49.32 USD | 2877814.923% |
| Accustem Sciences Inc. | - USD | Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 103.525% |
| EV Biologics, Inc. | 48.9 Thousand USD | 3002.431% |
| Q BioMed Inc. | -8988.00 USD | -15690.932% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 105.023% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | -9101.822% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 100.645% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 2127.556% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | -1042.276% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 2380.862% |
| THC Farmaceuticals, Inc. | -4952.00 USD | -28560.925% |
| Arch Therapeutics, Inc. | -2439.00 USD | -58091.431% |
| IMV Inc. | -962.29 Thousand USD | -47.49% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 1110.17% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | -1355.457% |
| GB Sciences, Inc. | -624.00 USD | -227350.16% |
| Alpha Cognition Inc. | -86.02 Thousand USD | -1549.799% |
| HST Global, Inc. | - USD | Infinity% |
| CSL Limited | 7.56 Billion USD | 100.019% |
| Halberd Corporation | -208.00 USD | -682250.481% |
| Enzolytics Inc. | 30.7 Thousand USD | 4721.887% |
| Resverlogix Corp. | - USD | Infinity% |
| Affymax, Inc. | 1.35 Million USD | 204.579% |
| SYBLEU INC | 11.69 Thousand USD | 12234.824% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 394.194% |
| argenx SE | 1.1 Billion USD | 100.128% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 94.498% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 329.888% |
| Zenith Capital Corp. | - USD | Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 100.347% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | -15926.299% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 103.2% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | -24.328% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 243.655% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 114.767% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | -1592.673% |
| BioStem Technologies, Inc. | 15.42 Million USD | 109.201% |
| ONE Bio Corp. | 20.12 Million USD | 107.052% |
| Reve Technologies, Inc. | - USD | Infinity% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Agentix Corp. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | -11892.302% |
| Cell Source, Inc. | - USD | Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | -2840.983% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 903.856% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 903.856% |
| NovAccess Global Inc. | - USD | Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | -175.853% |
| Itoco Inc. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | -125.235% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| CytoDyn Inc. | -29 Thousand USD | -4794.1% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| Mobile Lads Corp. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Qrons Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 415.367% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | -344.212% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 130.801% |
| Bioxytran, Inc. | -8285.00 USD | -17030.827% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | -280.506% |
| Neutra Corp. | 14.33 Thousand USD | 10000.865% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -1630.84% |
| PureTech Health plc | -1.6 Million USD | 11.46% |
| Coeptis Therapeutics, Inc. | -1 Million USD | -41.754% |
| IXICO plc | 3.27 Million USD | 143.403% |
| IntelGenx Technologies Corp. | -694 Thousand USD | -104.509% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 20.754% |
| CSL Limited | 7.7 Billion USD | 100.018% |
| Cellectis S.A. | 18 Thousand USD | 7984.939% |